Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Devyser Diagnostics AB (DVYSR) Price & Analysis

DVYSR Stock Chart & Stats

SEK 55.00-SEK 3.00(-5.17%)
At close: 4:00 PM EDT
SEK 50SEK 55SEK 60SEK 653 Aug17 Aug31 Aug14 Sep28 Sep12 Oct26 Oct
Day’s Range
SEK 55.00 - SEK 58.00
52-Week Range
SEK 48.50 - SEK 131.80
Previous Close
SEK 58.00
Volume
16.23K
Average Volume (3M)
21.75K
Market Cap
SEK 928.94M
Enterprise Value
SEK 1.41B
Total Cash (Recent Filing)
SEK 81.00M
Total Debt (Recent Filing)
SEK 45.80M
Price to Earnings (P/E)
59.8
Beta
0.55
Next Earnings
Nov 03, 2026
EPS Estimate
0.07
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Profitability Inflection

The return to positive earnings alongside strong gross and operating margins indicates a meaningful improvement in the economics of the business. If maintained, this profitability provides greater capacity to fund product development, commercial expansion, and operations without relying as heavily on external capital.

Conservative Balance Sheet

Low leverage gives Devyser financial flexibility while it develops and commercializes genetic testing products. A substantial equity base and declining debt reduce balance-sheet pressure, improve resilience during uneven demand, and leave more room to invest in growth or absorb operational setbacks.

Improved Cash Generation

The shift to positive operating and free cash flow is an important sign that the improved earnings profile is beginning to support internal funding. Sustained cash generation would strengthen Devyser’s ability to finance ongoing commercialization and product investment while limiting dependence on new borrowing or equity.

Bears Say

Revenue Contraction

A declining revenue base limits the durability of the current earnings improvement because margin gains cannot compound indefinitely without renewed demand. Continued contraction could weaken scale benefits, constrain commercial investment, and make future growth more dependent on further efficiency gains.

Uneven Cash Conversion

Positive cash flow is encouraging, but the low conversion of reported earnings into free cash flow raises questions about how consistently profits become deployable funds. Continued uneven conversion could restrict self-financed expansion and make cash planning more difficult across operating cycles.

Modest Returns After Losses

The recent profitability improvement has not yet translated into strong returns on the capital invested in the business. Low ROE and the history of annual losses indicate that earnings quality and operating efficiency still need to mature, leaving less evidence of a consistently durable profit model.

DVYSR FAQ

What was Devyser Diagnostics AB’s price range in the past 12 months?
Devyser Diagnostics AB lowest stock price was kr 48.50 and its highest was kr 131.80 in the past 12 months.
What is Devyser Diagnostics AB’s market cap?
Devyser Diagnostics AB’s market cap is kr 928.94M.
When is Devyser Diagnostics AB’s upcoming earnings report date?
Devyser Diagnostics AB’s upcoming earnings report date is Nov 03, 2026 which is in 2 days.
How were Devyser Diagnostics AB’s earnings last quarter?
Devyser Diagnostics AB released its earnings results on Jul 20, 2026. The company reported kr 0.096 earnings per share for the quarter, missing the consensus estimate of kr 0.393 by -kr 0.297.
Is Devyser Diagnostics AB overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Devyser Diagnostics AB pay dividends?
Devyser Diagnostics AB does not currently pay dividends.
What is Devyser Diagnostics AB’s EPS estimate?
Devyser Diagnostics AB’s EPS estimate is 0.07.
How many shares outstanding does Devyser Diagnostics AB have?
Devyser Diagnostics AB has 16,889,807 shares outstanding.
What happened to Devyser Diagnostics AB’s price movement after its last earnings report?
Devyser Diagnostics AB reported an EPS of kr 0.096 in its last earnings report, missing expectations of kr 0.393. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Devyser Diagnostics AB?
Currently, no hedge funds are holding shares in SE:DVYSR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology